These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21464006)

  • 1. [Establishment of outcome-related analytic performance goals].
    Klee GG
    Ann Biol Clin (Paris); 2011; 69(2):139-50. PubMed ID: 21464006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of outcome-related analytic performance goals.
    Klee GG
    Clin Chem; 2010 May; 56(5):714-22. PubMed ID: 20348409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Six Sigma: not for the faint of heart.
    Benedetto AR
    Radiol Manage; 2003; 25(2):40-53. PubMed ID: 12800564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The quality of laboratory testing today: an assessment of sigma metrics for analytic quality using performance data from proficiency testing surveys and the CLIA criteria for acceptable performance.
    Westgard JO; Westgard SA
    Am J Clin Pathol; 2006 Mar; 125(3):343-54. PubMed ID: 16613337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A system to monitor a portion of the total testing process in medical clinics and laboratories: feasibility of a split-specimen design.
    Shahangian S; Krolak JM; Gaunt EE; Cohn RD
    Arch Pathol Lab Med; 1998 Jun; 122(6):503-11. PubMed ID: 9625417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interinstitutional comparison of bedside blood glucose monitoring program characteristics, accuracy performance, and quality control documentation: a College of American Pathologists Q-Probes study of bedside blood glucose monitoring performed in 226 small hospitals.
    Novis DA; Jones BA
    Arch Pathol Lab Med; 1998 Jun; 122(6):495-502. PubMed ID: 9625416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The external quality assessment schemes in Thailand.
    Opartkiattikul N; Bejrachandra S
    Rinsho Byori; 2002 Feb; 50(2):121-5. PubMed ID: 11925846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation and application of analytical goals in laboratory medicine.
    Fraser CG
    Ann Ist Super Sanita; 1991; 27(3):369-75. PubMed ID: 1809055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance goals for the laboratory testing of antithrombin, protein C and protein S.
    Meijer P; Haverkate F; Kluft C
    Thromb Haemost; 2006 Nov; 96(5):584-9. PubMed ID: 17080214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Lebanese External Quality Assessment Scheme for laboratories: was it worth establishing?
    Hallak G
    J Med Liban; 2005; 53(1):9-15. PubMed ID: 16398207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External quality assurance in Malaysia.
    Nawawi H; Lim HH; Zakiah I
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():39-45. PubMed ID: 10926257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evidence-based use of clinical biochemistry].
    Jørgensen PE; Madsen JS; Larsen TB; Hilden J; Magid E
    Ugeskr Laeger; 2001 Oct; 163(42):5815-9. PubMed ID: 11685853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What information on quality specifications should be communicated to clinicians, and how?
    Plebani M
    Clin Chim Acta; 2004 Aug; 346(1):25-35. PubMed ID: 15234633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of data derived from biological variation into the quality management system.
    Ricós C; Alvarez V; Cava F; García-Lario JV; Hernández A; Jiménez CV; Minchinela J; Perich C; Simón M
    Clin Chim Acta; 2004 Aug; 346(1):13-8. PubMed ID: 15234631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance goals for internal quality control of multichannel haematology analysers.
    Klee GG
    Clin Lab Haematol; 1990; 12 Suppl 1():65-74. PubMed ID: 2282767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reprint of "Influence of analytical bias and imprecision on the number of false positive results using Guideline-Driven Medical Decision Limits".
    Hyltoft Petersen P; Klee GG
    Clin Chim Acta; 2014 May; 432():127-34. PubMed ID: 24747109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.